DK126116B - Analogifremgangsmåde til fremstilling af oxazolidinderivater eller salte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af oxazolidinderivater eller salte deraf.

Info

Publication number
DK126116B
DK126116B DK354166AA DK354166A DK126116B DK 126116 B DK126116 B DK 126116B DK 354166A A DK354166A A DK 354166AA DK 354166 A DK354166 A DK 354166A DK 126116 B DK126116 B DK 126116B
Authority
DK
Denmark
Prior art keywords
salts
preparation
analogous process
oxazolidine derivatives
oxazolidine
Prior art date
Application number
DK354166AA
Other languages
Danish (da)
English (en)
Inventor
Sa Ciba
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1585465A external-priority patent/CH500216A/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK126116B publication Critical patent/DK126116B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK354166AA 1965-07-09 1966-07-08 Analogifremgangsmåde til fremstilling af oxazolidinderivater eller salte deraf. DK126116B (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH1432269A CH490405A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH962965A CH484172A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung eines neuen Oxazolidinons
CH1585565A CH512504A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidin-2-on-verbindungen
CH1585465A CH500216A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH505966A CH507271A (de) 1965-07-09 1966-04-06 Verfahren zur Herstellung von neuen Oxazolidin-2-thion-Verbindungen
CH667066 1966-05-06

Publications (1)

Publication Number Publication Date
DK126116B true DK126116B (da) 1973-06-12

Family

ID=27543759

Family Applications (2)

Application Number Title Priority Date Filing Date
DK354266AA DK125893B (da) 1965-07-09 1966-07-08 Analogifremgangsmåde til fremstilling af 3-isopropyl-5-(o-allyloxyphenoxy-methyl)-oxazolidinon-(2).
DK354166AA DK126116B (da) 1965-07-09 1966-07-08 Analogifremgangsmåde til fremstilling af oxazolidinderivater eller salte deraf.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK354266AA DK125893B (da) 1965-07-09 1966-07-08 Analogifremgangsmåde til fremstilling af 3-isopropyl-5-(o-allyloxyphenoxy-methyl)-oxazolidinon-(2).

Country Status (11)

Country Link
US (2) US3455946A (fr)
AT (6) AT268276B (fr)
BE (2) BE683867A (fr)
BR (2) BR6681113D0 (fr)
CH (4) CH484172A (fr)
DE (2) DE1670358A1 (fr)
DK (2) DK125893B (fr)
FR (4) FR1503574A (fr)
GB (2) GB1108538A (fr)
NL (2) NL6609639A (fr)
SE (2) SE324571B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546231A (en) * 1968-05-03 1970-12-08 Ansul Co Certain 2-(pyridyl-3-thiocarbamoyl-1,3-oxazolidines)
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
IT1109002B (it) * 1977-09-22 1985-12-16 Menarini Sas Derivati del 2 oxazolidone e loro metodi di preparazione
DE3205457A1 (de) * 1982-02-16 1983-08-25 Merck Patent Gmbh, 6100 Darmstadt Oxazolidin-2-one
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
ES8503657A1 (es) * 1983-07-06 1985-04-01 Fabr Prod Quimicos Y Farmaceut Un procedimiento para la preparacion de derivados de 3-sulfonamidopiridinas 2 -sustituidas.
JP2008303145A (ja) * 2005-09-22 2008-12-18 Takeda Chem Ind Ltd Grk阻害剤からなる強心薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB834968A (en) * 1957-08-28 1960-05-18 Robins Co Inc A H 5-o-alkoxyphenoxymethyl-2-oxazolidones
NL131194C (fr) * 1963-07-19

Also Published As

Publication number Publication date
GB1108538A (en) 1968-04-03
AT268276B (de) 1969-02-10
DE1670357A1 (de) 1970-10-29
CH512504A (de) 1971-09-15
US3480640A (en) 1969-11-25
BR6681113D0 (pt) 1973-12-26
CH507271A (de) 1971-05-15
FR5727M (fr) 1968-01-22
DK125893B (da) 1973-05-21
AT269137B (de) 1969-03-10
SE324571B (fr) 1970-06-08
BE683868A (fr) 1967-01-09
FR5728M (fr) 1968-01-22
CH484172A (de) 1970-01-15
DE1670358A1 (de) 1970-10-29
FR1503574A (fr) 1967-12-01
GB1106594A (en) 1968-03-20
SE324775B (fr) 1970-06-15
CH490405A (de) 1970-05-15
AT266127B (de) 1968-11-11
NL6609639A (fr) 1967-01-10
BR6681111D0 (pt) 1973-12-26
FR6015M (fr) 1968-05-06
NL6609640A (fr) 1967-01-10
AT266128B (de) 1968-11-11
AT266129B (de) 1968-11-11
BE683867A (fr) 1967-01-09
US3455946A (en) 1969-07-15
AT266832B (de) 1968-12-10

Similar Documents

Publication Publication Date Title
DK121866B (da) Fremgangsmåde til fremstilling af aryloxyalkanolaminderivater eller salte deraf.
DK111418B (da) Fremgangsmåde til fremstilling af benzanilidderivater eller salte deraf.
DK115926B (da) Fremgangsmåde til fremstilling af thebain- eller oripavinderivater eller salte deraf.
DK136608B (da) Fremgangsmåde til fremstilling af 1,2,4-oxadiazolderivater eller salte deraf.
DK121365B (da) Analogifremgangsmåde til fremstilling af 4-chlor-5-sulfamylsalicylsyrederivater eller salte deraf.
DK123238B (da) Analogifremgangsmåde til fremstilling af piperidinderivater eller salte deraf.
DK108574C (da) Fremgangsmåde til fremstilling af derivater af 7-oxy-2-oxo-1,2-dihydrogenquinolin eller salte deraf.
DK118457B (da) Analogifremgangsmåde til fremstilling af bis-guanylhydrazoner af diphenylurinstoffer eller salte deraf.
DK126116B (da) Analogifremgangsmåde til fremstilling af oxazolidinderivater eller salte deraf.
DK117963B (da) Fremgangsmåde til fremstilling af aryloxyalkanolaminderivater eller salte deraf.
DK123870B (da) Analogifremgangsmåde til fremstilling af phenoxazinderivater eller salte deraf.
DK109868C (da) Fremgangsmåde til fremstilling af oxazolidinderivater eller salte deraf.
DK114983B (da) Fremgangsmåde til fremstilling af triarylalkanderivater eller salte deraf.
DK107095C (da) Fremgangsmåde til fremstilling af azcycloalkanderivater eller salte deraf.
DK121054B (da) Analogifremgangsmåde til fremstilling af spiro-azatetramethylenderivater eller salte deraf.
DK115182B (da) Fremgangsmåde til fremstilling af morpholinderivater eller salte deraf.
DK112528B (da) Fremgangsmåde til fremstilling af tropanyl-2-phenylacrylatderivater eller salte deraf.
DK115187B (da) Fremgangsmåde til fremstilling af alkanolaminderivater eller salte deraf.
DK116129B (da) Fremgangsmåde til fremstilling af piperidinderivater eller salte deraf.
DK118509B (da) Fremgangsmåde til fremstilling af 1,1-diphenyl-1-metoxy-3-benzylaminopropan eller salte heraf.
DK117494B (da) Fremgangsmåde til fremstilling af 4-aminoantipyriderivater eller salte deraf.
DK117146B (da) Fremgangsmåde til fremstilling af 5- eller 3-sulfanilamido-4-methoxy-isoxazoler eller salte deraf.
DK113652B (da) Fremgangsmåde til fremstilling af naphthoxypropanolderivater eller salte deraf.
DK106553C (da) Fremgangsmåde til fremstilling af indol-derivater eller salte deraf.
DK113019B (da) Fremgangsmåde til fremstilling af N-dichloracetyl-β-(p-fluorphenyl)-alanin eller salte deraf.